{"name": "Lev Pharmaceuticals",
 "permalink": "lev-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/lev-pharmaceuticals",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": 26,
 "founded_year": 2003,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "212-682-3096",
 "description": "",
 "created_at": "Tue Sep 15 01:20:02 UTC 2009",
 "updated_at": "Thu Aug 18 03:39:30 UTC 2011",
 "overview": "\u003Cp\u003ELev Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Its products include C1-INH that is used for the treatment of hereditary angioedema. The company was founded in 2003 and is based in New York, New York. As of October 21, 2008, Lev Pharmaceuticals, Inc. operates as a subsidiary of ViroPharma Inc.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       32],
      "assets/images/resized/0014/9972/149972v1-max-150x150.png"],
     [[219,
       47],
      "assets/images/resized/0014/9972/149972v1-max-250x250.png"],
     [[219,
       47],
      "assets/images/resized/0014/9972/149972v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Co-founder ",
    "person":
     {"first_name": "Joshua",
      "last_name": "D. Schein",
      "permalink": "joshua-d-schein",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Douglas",
      "last_name": "Beck",
      "permalink": "douglas-beck",
      "image": null}},
   {"is_past": false,
    "title": "Co-founder ",
    "person":
     {"first_name": "Judson",
      "last_name": "A. Cooper",
      "permalink": "judson-a-cooper",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$41M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_8/ai_n27439678/",
    "source_description": "Lev Pharmaceuticals Announces $20 Million Senior Secured Term Loan Facility",
    "raised_amount": 20000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 11,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Mast Capital Management",
         "permalink": "mast-capital-management",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0026/1011/261011v1-max-150x150.png"],
             [[250,
               94],
              "assets/images/resized/0026/1011/261011v1-max-250x250.png"],
             [[428,
               162],
              "assets/images/resized/0026/1011/261011v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.biospace.com/news_story.aspx?StoryID=34029",
    "source_description": "Lev Pharmaceuticals, Inc. Announces $21 Million Private Placement ",
    "raised_amount": 21000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 10,
    "funded_day": 23,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Southpoint Capital Advisors",
         "permalink": "southpoint-capital-advisors",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/4384/44384v1-max-150x150.jpg"],
             [[250,
               65],
              "assets/images/resized/0004/4384/44384v1-max-250x250.jpg"],
             [[346,
               91],
              "assets/images/resized/0004/4384/44384v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Hound Partners",
         "permalink": "hound-partners",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Emigrant Capital",
         "permalink": "emigrant-capital",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0010/1956/101956v2-max-150x150.png"],
             [[200,
               110],
              "assets/images/resized/0010/1956/101956v2-max-250x250.png"],
             [[200,
               110],
              "assets/images/resized/0010/1956/101956v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alexandra Investment Management",
         "permalink": "alexandra-investment-management",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0001/0893/10893v1-max-150x150.png"],
             [[250,
               68],
              "assets/images/resized/0001/0893/10893v1-max-250x250.png"],
             [[337,
               92],
              "assets/images/resized/0001/0893/10893v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Rosalind Capital Partners",
         "permalink": "rosalind-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0026/1145/261145v1-max-150x150.png"],
             [[202,
               59],
              "assets/images/resized/0026/1145/261145v1-max-250x250.png"],
             [[202,
               59],
              "assets/images/resized/0026/1145/261145v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 585890000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.fiercebiotech.com/press-releases/viropharma-acquire-lev-pharmaceuticals",
   "source_description": "ViroPharma To Acquire Lev Pharmaceuticals ",
   "acquired_year": 2008,
   "acquired_month": 7,
   "acquired_day": 15,
   "acquiring_company":
    {"name": "ViroPharma",
     "permalink": "viropharma",
     "image":
      {"available_sizes":
        [[[150,
           66],
          "assets/images/resized/0005/9762/59762v2-max-150x150.jpg"],
         [[250,
           109],
          "assets/images/resized/0005/9762/59762v2-max-250x250.jpg"],
         [[450,
           197],
          "assets/images/resized/0005/9762/59762v2-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "675 Third Avenue",
    "address2": "Suite 2200",
    "zip_code": "10017",
    "city": "New York",
    "state_code": "NY",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}